Sarepta Therapeutics (SRPT)

Add to Watchlists
Create an Alert
24.40 +0.17  +0.70% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
SRPT Price Chart
View All Events

SRPT Events

Date Type Description
Feb 27 Misc Sarepta Therapeutics Inc Q4 2013 Earning Conference Call
Feb 27 Earnings Sarepta Therapeutics Inc Q4 2013 Earning Result. Estimate: -0.70.
Nov 12 Misc Sarepta Therapeutics to Announce Third Quarter 2013 Financial Conference Call
Nov 12 Earnings Sarepta Therapeutics to Announce Third Quarter 2013 Financial Results. Estimate: -0.66.
Oct 17 Misc Cambridge, Ma -- (Marketwired) -- 10/10/13 -- Sarepta Therapeutics, Inc. (Nasdaq: Srpt), a Developer of Innovative Rna-based Therapeutics, Will Host a Webcast and Conference Call for the Duchenne Muscular Dystrophy (Dmd) Community on Thursday, Octobe
Aug 08 Misc Cambridge, Ma -- (Marketwired) -- 07/25/13 -- Sarepta Therapeutics, Inc. (Nasdaq: Srpt), a Developer of Innovative Rna-based Therapeutics, Will Report Second Quarter Financial Results Before the Nasdaq Global Market Opens on Thursday, August 8, 2013.
Aug 08 Earnings Sarepta Therapeutics to Announce Second Quarter 2013 Financial Results and Corporate Update on August 8, 2013. Estimate: -0.72.
Jul 24 Misc Sarepta Therapeutics Regulatory Update Call
Jun 04 Misc AGM Event for Sarepta Therapeutics Inc
May 09 Misc Cambridge, Ma -- (Marketwired) -- 04/26/13 -- Sarepta Therapeutics, Inc. (Nasdaq: Srpt), a Developer of Innovative Rna-based Therapeutics, Will Report First Quarter Financial Results Before the Nasdaq Global Market Opens on Thursday, May 9, 2013. Sub
View All Performance Charts

SRPT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Sarepta Therapeutics is down 30.54% over the last year vs S&P 500 Total Return up 23.54%, Prosensa Holding up N/A, and Jazz Pharmaceuticals up 148.9%.

Get Quote for

PDF Report for SRPT

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download SRPT Pro Report PDF
Advertisement

Portfolio Strategies Featuring SRPT

Did Sarepta Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

SRPT Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Oregon
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include eteplirsen, AVI-6002, AVI-6003, and AVI-7100.

Recent Quotes

Symbol Price Chg Chg % Market Cap
SRPT 24.40 +0.17 +0.70% 921.71M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.